Clinical potential of ATM inhibitors-Reference-Cited by-同舟云学术

Clinical potential of ATM inhibitors

Published:2020-05 Issue: Volume:821 Page:111695
ISSN:0027-5107
Container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
language:en
Short-container-title:Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Author:

Lavin Martin F.,Yeo Abrey J.

Funder

Australian Ataxia-Telangiectasia Organization, BrAshA-T

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics,Molecular Biology

Reference114 articles.

1. A single ataxia telangiectasia gene with a product similar to PI-3 kinase;Savitsky;Science,1995

2. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer;Lavin;Nat. Rev. Mol. Cell Biol.,2008

3. Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium;Lange;Am. J. Hum. Genet.,1995

4. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species;Savitsky;Hum. Mol. Genet.,1995

5. Interaction between ATM protein and c-Abl in response to DNA damage;Shafman;Nature,1997

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of ATM inhibitors: Opportunities and challenges;European Journal of Medicinal Chemistry;2024-11

2. An update on small molecule compounds targeting synthetic lethality for cancer therapy;European Journal of Medicinal Chemistry;2024-11

3. DNA damage response-related ncRNAs as regulators of therapy resistance in cancer;Frontiers in Pharmacology;2024-08-26

4. Adaptive resistance to FLT3 inhibitors is potentiated by ROS-driven DNA repair signalling;2024-07-26

5. A comprehensive review of computational cell cycle models in guiding cancer treatment strategies;npj Systems Biology and Applications;2024-07-05